Sandbox/20: Difference between revisions
< Sandbox
Line 53: | Line 53: | ||
|} | |} | ||
==== | ====Specific Therapy—Positive culture of CSF with in vitro susceptibility results available==== | ||
{| class="wikitable" border="1" style="background:Snow; font-size:85%;" | |||
|- | |||
|style="width:10%"|'''Bacteria''' | |||
|style="width:20%"|'''Specific Lab Findings''' | |||
|style="width:35%"|'''Preferred Regimen''' | |||
|style="width:35%"|'''Alternative Regimen''' | |||
|- | |||
| ''''' Haemophilus influenzae''''' || '''''ȕ-lactamase positive ''''' ||'''''[[Ceftriaxone]] (peds): 50 mg/kg IV | |||
q12h|| [[Penicillin|Pen.]] allergic: [[Chlorine]] 12.5 mg/kg IV q6h (max. 4 gm/day.) | |||
|- | |||
| '''''Listeria monocytogenes ''''' || ||'''''[[Ampicillin]] 2 gm IV q4h ''''' <BR> ''PLUS OR NOT'' <BR> '''''[[Gentamicin]] 2 mg/kg loading dose, then 1.7 mg/kg q8h'''''||'''''If pen-allergic, use [[Co-trimoxazole|TMP-SMX]] 20 mg/kg per day div. q6–12h''''' <BR> ''Alternative: <BR> '''''1. [[Meropenem]]2 gm IV q8h ''''' <BR> '''''2.[[linezolid]]''''' <BR> ''PLUS'' <BR> '''''[[Rifampin]]''''' | |||
|- | |||
| '''''[[Neisseria meningitidis]]''''' ||'''''[[Pencillin|Pen.]] MIC 0.1–1 mcg per mL ''''' ||'''''[[Ceftriaxone]] 2 gm IV q12h x 7 days '''''; if ȕ-lactam allergic, '''''[[Chlorine]] 12.5 mg/kg (up to 1 gm) IV q6h ''''' ||'''''[[Meropenem]] 2 gm IV q8h''''' ''OR'' ''''' [[moxifloxacin]] 400 mg q24h''''' | |||
|- | |||
| '''''Gram-negative bacilli ''''' || '''''[[Haemophilus influenzae]], '''''coliforms''''', [[Pseudomonas aeruginosa]]'''''||'''''[[Ceftazidime]]''''' ''OR'' [[Cefepime]] 2 gm IV q8h''''' <BR> ''PLUS'' <BR> '''''Gentamicin 2 mg/kg 1st dose then 1.7 mg/kg q8h '''''||'''''[[Ciprofloxacin]] 400 mg IV q8–12h'''''; '''''[[Meropenem]] 2 gm IV q8h''''' | |||
|- | |||
|} | |||
==Pathogen-Specific Therapy== | ==Pathogen-Specific Therapy== |
Revision as of 16:21, 16 December 2013
Bacterial Meningitis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Diagnosis
- Bacterial meningitis is the infection of meninges by bacteria.
Empiric Therapy
Negative CSF Gram Stain
Group | Etiology | Preferred Regimen | Alternative Regimen |
Preterm—1 mo | Streptococcus agalactiae (49%) Escherichia coli (18%) misc. Gram-positive (10%) misc. Gram-negative (10%) Listeria (7%) |
Ampicillin PLUS Cefotaxime (for dosage see footnote) |
Ampicillin PLUS Gentamicin (for dosage see footnote) |
1 mo—50 yrs | Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae† |
Adult dosage:Cefotaxime 2 gm IV q4—6h OR Ceftriaxone 2 gm IV q12h PLUS Vancomycin 500—750 mg IV q6h‡ PLUS Dexamethasone 'Peds:'Cefotaxime 200 mg/kg per day IV div. q6–8h; Ceftriaxone 100 mg/kg per day IV div. q12h; Vancomycin 15 mg/kg IV q6h. |
Meropenem2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity | Streptococcus pneumoniae listeriaGram-negative bacilli |
Ampicillin 2 gm IV q4h PLUS 'Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q6h PLUS Vancomycin PLUS IV Dexamethasone |
Meropenem 2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
Post-neurosurgery, post-head trauma, or post-cochlear implant | Streptococcus pneumoniae most common, esp. if CSF leak. Other: Staphylococcus aureus, coliforms, Pseudomonas aeruginosa |
Vancomycin (until known not MRSA) 500–750 mg IV q6h2' PLUS Cefepime or Ceftazidime 2 gm IV q8h |
Meropenem 2 gm IV q8h PLUS Vancomycin1 gm IV q6–12h |
Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt | Staphylococcus epidermidis,Staphylococcus aureus,coliforms,diphtheroids (rare),'Propionibacterium acnes | Vancomycin 500–750 mg IV q6h PLUS cefepime or ceftazidime 2 gm IV q8h |
Vancomycin 500–750 mg IV q6h PLUS Meropenem 2 gm IV q8h |
† H. influenzae now very rare, listeria unlikely if young & immuno-competent (add ampicillin if suspect listeria: 2 gm IV q4h)
‡ Children’s dosage 15 mg/kg IV q6h (2x standard adult dose). In adults, max dose of 2-3 gm/day is suggested: 500–750 mg IV q6h.
Postive CSF Gram Stain
Group | Etiology | Preferred Regimen | Alternative Regimen |
Gram-positive diplococci | S.pneumoniae | Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q4–6h PLUS Vancomycin 500–750 mg IV q6h PLUS timed Dexamethasone 0.15 mg/kg q6h IV x 2–4 days |
Meropenem 2 gm IV q8h OR Moxifloxacin 400 mg IV q24h |
Gram-negative diplococci | N. meningitidis | Cefotaxime 2 gm IV q4–6h OR Ceftriaxone 2 gm IV q12h | Penicillin G 4 mill. units IV q4h OR Ampicillin 2 gm q4h OR Moxifloxacin 400 mg IV
q24h OR Chloro 1 gm IV q6h |
1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity | Streptococcus pneumoniae listeriaGram-negative bacilli |
Ampicillin 2 gm IV q4h PLUS 'Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q6h PLUS Vancomycin PLUS IV Dexamethasone |
Meropenem 2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
Post-neurosurgery, post-head trauma, or post-cochlear implant | Streptococcus pneumoniae most common, esp. if CSF leak. Other:Staphylococcus aureus, coliforms, Pseudomonas aeruginosa |
Vancomycin (until known not MRSA) 500–750 mg IV q6h2' PLUS Cefepime or Ceftazidime 2 gm IV q8h |
Meropenem 2 gm IV q8h PLUS Vancomycin1 gm IV q6–12h |
Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt | Staphylococcus epidermidis,Staphylococcus aureus,coliforms,diphtheroids (rare),'Propionibacterium acnes | Vancomycin 500–750 mg IV q6h PLUS cefepime or ceftazidime 2 gm IV q8h |
Vancomycin 500–750 mg IV q6h PLUS Meropenem 2 gm IV q8h |
Specific Therapy—Positive culture of CSF with in vitro susceptibility results available
Bacteria | Specific Lab Findings | Preferred Regimen | Alternative Regimen |
Haemophilus influenzae | ȕ-lactamase positive | Ceftriaxone (peds): 50 mg/kg IV
q12h|| Pen. allergic: Chlorine 12.5 mg/kg IV q6h (max. 4 gm/day.) | |
Listeria monocytogenes | Ampicillin 2 gm IV q4h PLUS OR NOT Gentamicin 2 mg/kg loading dose, then 1.7 mg/kg q8h |
If pen-allergic, use TMP-SMX 20 mg/kg per day div. q6–12h Alternative: 1. Meropenem2 gm IV q8h 2.linezolid PLUS Rifampin | |
Neisseria meningitidis | Pen. MIC 0.1–1 mcg per mL | Ceftriaxone 2 gm IV q12h x 7 days ; if ȕ-lactam allergic, Chlorine 12.5 mg/kg (up to 1 gm) IV q6h | Meropenem 2 gm IV q8h OR moxifloxacin 400 mg q24h |
Gram-negative bacilli | Haemophilus influenzae, coliforms, Pseudomonas aeruginosa | Ceftazidime OR Cefepime 2 gm IV q8h PLUS Gentamicin 2 mg/kg 1st dose then 1.7 mg/kg q8h |
Ciprofloxacin 400 mg IV q8–12h; Meropenem 2 gm IV q8h |